Dr Andreas Amrein joins Advanced Clinical to lead global development and expansion in APAC
Drug Discovery | News | 0 Comment | 10 Mar, 2022
Advanced Clinical, a clinical development and strategic resourcing organization committed to providing a better clinical...Read more
China approves phase II trial of Akeso's cancer drug
Drug Discovery | News | 0 Comment | 08 Mar, 2022
Akeso, Inc., a biopharmaceutical company dedicated to the development of innovative antibody drugs, has announced that t...Read more
I-Mab receives FDA orphan drug designation for cancer drug
Drug Discovery | News | 0 Comment | 04 Mar, 2022
China based I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercializa...Read more
China-based startup InxMed raises $50 M in Series B Financing
Drug Discovery | News | 0 Comment | 04 Mar, 2022
InxMed Co., Ltd, a clinical-stage biotechnology startup based in China, has announced that it had completed $5...Read more
China's Adagene partners with French firm Sanofi for Immuno-Oncology
Drug Discovery | News | 0 Comment | 03 Mar, 2022
China's Adagene, a company transforming the discovery and development of antibody-based therapies, has announced a...Read more
China approves Phase II clinical trial of InnoCare's cancer drug
Drug Discovery | News | 0 Comment | 03 Mar, 2022
InnoCare Pharma, a leading biopharmaceutical company, has announced the Investigational New Drug (IND) approval of its B...Read more
China-based Fosun Pharma and Insilico Medicine advance AI-driven drug discovery
Drug Discovery | News | 0 Comment | 12 Jan, 2022
Shanghai Fosun Pharmaceutical (Group) Co. and Insilico Medicine have entered into a collaboration agreement to advance t...Read more
Taiwan's GoldenBiotech suggests 100% recovery with oral drug Antroquinonol in COVID-19 patients
Drug Discovery | News | 0 Comment | 10 Jan, 2022
Golden Biotechnology Corp., a leading Taiwanese biopharmaceutical company, has announced that its Phase 2 COVID-19 trial...Read more
Korean startup Astrogen to use AI for drug design against Parkinson’s Disease
Drug Discovery | News | 1 Comment | 06 Jan, 2022
South Korea-based startup Astrogen and Paris-based firm Iktos have announced a research collaboration to use A...Read more
Japan's PRISM BioLab partners with Roche and Genentech for drug discovery research
Drug Discovery | News | 0 Comment | 05 Jan, 2022
PRISM BioLab, a Japan based biotechnology company with a proprietary peptide mimetic small molecule drug discovery ...Read more
China’s BeiGene expands collaboration with Novartis for oncology medicines
Drug Discovery | News | 0 Comment | 28 Dec, 2021
China-based BeiGene has announced an option, collaboration and license agreement with Novartis Pharma AG to develop, man...Read more
Merck and Ridgeback’s COVID-19 pill receives ‘special approval’ in Japan
Drug Discovery | News | 0 Comment | 27 Dec, 2021
Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics have announced that Japan’...Read more
Korea offers niclosamide-based drug as possible cure for COVID-19 variants
Drug Discovery | News | 0 Comment | 08 Dec, 2021
Experimental results have been published for the first time showing that an antiviral drug containing niclosamide, an an...Read more
Standigm, Institut Pasteur Korea team up for AI-based drug discovery research on TB
Drug Discovery | News | 0 Comment | 02 Dec, 2021
South Korea-based startup Standigm Inc. has announced the signing of a Memorandum of Understanding (MoU) with Institut P...Read more
Tackling onerousness drug development process through cost-effective genomic analysis platforms
Drug Discovery | Opinion | By Hithaishi C Bhaksar | 2 Comment | 02 Dec, 2021
The limitations of the existing drug discovery paradigm reveals that there are still no effective prevention or real cur...Read more
Holistic drug development strategy improves probability of success in oncology therapeutics
Drug Discovery | Opinion | By Hithaishi C Bhaksar | 2 Comment | 22 Nov, 2021
AUM Biosciences is a global clinical-stage biotech company, focused on discovering and developing novel target...Read more
Pfizer inks deal worth $5.29 B with US government for COVID-19 pill
Drug Discovery | News | 0 Comment | 19 Nov, 2021
Pfizer Inc. has announced an agreement with the US government to supply 10 million treatment courses of its investi...Read more
Pfizer seeks EUA for novel oral COVID-19 pill
Drug Discovery | News | 0 Comment | 17 Nov, 2021
Pfizer Inc. has announced that it is seeking Emergency Use Authorization (EUA) of its investigational oral antivira...Read more